Provided by Tiger Trade Technology Pte. Ltd.

Genmab A/S

33.16
-0.0700-0.21%
Pre-market: 32.82-0.3413-1.03%04:10 EDT
Volume:1.73M
Turnover:57.25M
Market Cap:20.39B
PE:26.21
High:33.26
Open:32.76
Low:32.54
Close:33.23
52wk High:35.43
52wk Low:23.62
Shares:615.00M
Float Shares:604.00M
Volume Ratio:0.74
T/O Rate:0.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.27
EPS(LYR):1.54
ROE:14.00%
ROA:8.79%
PB:3.42
PE(LYR):21.57

Loading ...

Genmab A/S Stock Falls Monday, Underperforms Market

Dow Jones
·
17 hours ago

Genmab A/S Stock Falls Friday, Underperforms Market

Dow Jones
·
Aug 29

Genmab A/S Stock Falls Wednesday, Underperforms Market

Dow Jones
·
Aug 27

Genmab A/S Stock Falls Monday, Underperforms Market

Dow Jones
·
Aug 25

Genmab A/S Stock Rises Friday, Underperforms Market

Dow Jones
·
Aug 22

Genmab A/S Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Aug 20

Genmab A/S Stock Rises Monday, Outperforms Market

Dow Jones
·
Aug 18

Genmab A/S Stock Rises Friday, Outperforms Market

Dow Jones
·
Aug 15

Genmab A/S Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Aug 13

Analysts Offer Insights on Healthcare Companies: Genmab (GMAB), Definitive Healthcare Corp (DH) and Atai Beckley N.V. (ATAI)

TIPRANKS
·
Aug 12

BNP Paribas Initiates Genmab at Outperform, With $40 Price Target

MT Newswires Live
·
Aug 12

Genmab A/S Stock Falls Monday, Underperforms Market

Dow Jones
·
Aug 11

Genmab A/S Stock Rises Friday, Outperforms Market

Dow Jones
·
Aug 08

Genmab price target raised to $42 from $40 at Guggenheim

TIPRANKS
·
Aug 07

Analysts Have Conflicting Sentiments on These Healthcare Companies: Genmab (GMAB), Cytokinetics (CYTK) and BioMarin Pharmaceutical (BMRN)

TIPRANKS
·
Aug 07

Analysts Are Bullish on Top Healthcare Stocks: Genmab (GMAB), Sotera Health (SHC)

TIPRANKS
·
Aug 07

Genmab raises FY26 revenue view to $4.325B-$4.525B from $4.065B-$4.395B

TIPRANKS
·
Aug 06

Press Release: Genmab Announces Financial Results for the First Half of 2026

Dow Jones
·
Aug 06

Genmab A/S Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Aug 06

Genmab Opens New Front in Solid Tumor Battle With GEN1119 Phase 1 Trial

TIPRANKS
·
Aug 05